David Aureliano PEREZ BERROCAL

Early-Stage Researcher

Partner Lab

The LUMC is a university medical centre for research, education and patient care with a high quality profile and a strong scientific orientation and ranks as the 6th best medical research institute in Europe (Shanghai 2015). It has a unique research practice, ranging from pure fundamental medical research to applied clinical research. This enables LUMC to offer patient care and education that is in line with the latest international insights and standards – and helps it to improve medicine and healthcare. The LUMC participates in the League of European Research Universities (LERU), a strong international network of 21 renowned research universities (www.leru.org). LUMC is also a member of the Coimbra group, placing it amongst the most prestigious universities in Europe.


David obtained his Bachelor’s degree in Chemistry at the University Complutense of Madrid (UCM). In his final year he moved to Wroclaw, Poland to carry out his final thesis in the  design of new 2.1.1 dioxatriphyrins and he specialised in organic chemistry.

After this he continued his education with a Master’s in Organic Chemistry at the UCM where he joined the MedChemLab headed by Mari-Luz López Rodríguez where he worked on the development of chemical probes for the identification of the molecular targets of cannabidiol, where his curiosity about the realm of medicinal chemistry was piqued.

David is joining the UbiCODE programme to pursue his PhD in Huib Ovaa’s laboratory where he will work on the development of chemical tools from small inhibitor targeting key role enzymes to Ubiquitin and ubiquitin-like (SUMO, NEDD4, heterochains) protein derivatives to gain further knowledge about the vast Ubiquitin Proteasome System (UPS). He will also develop assay reagents and better assays to shed light on the molecular features which remain in the dark making use of the expansive expertise of the team.